Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance medtronic¿s hawkone 6f directional atherectomy system.Survey results are received for a interventional cardiologist practicing in (b)(6).The respondent has been using the hawkone 6f directional atherectomy system since 2019 and has performed a total of 200 procedures using this system.During use of the hawkone 6f directional atherectomy system the respondent reports encountering the following device related complications: arterial dissection, arterial spasm, entry site complications, restenosis of the treated segment, total occlusion of the peripheral artery events were deemed device related.The total occlusion of the peripheral artery event was reported to be very concerning.The respondent classified the arterial dissection and restenosis of the treated segment events as somewhat concerning.The arterial spasm and entry site complications events were regarded as being not at all concerning.
|